Steris (NYSE: STE) reported Q4 EPS of $1.11, $0.05 better than the analyst estimate of $1.06. Revenue for the quarter came in at $681.2 million versus the consensus estimate of $673.61 million.

GUIDANCE:

Steris sees FY2018 EPS of $3.96-$4.09, versus the consensus of $3.72.

For earnings history and earnings-related data on Steris (STE) click here.